Endogenously generated DNA nucleobase modifications source, and significance as possible biomarkers of malignant

Ryszard Olinski1, Daniel Gackowski1, Marcus S Cooke2

  • 1Department of Clinical Biochemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Karlowicza 24, 85-095 Bydgoszcz, Poland.

Insights

DNA damage occurs daily in cells, but its location, not just level, may explain organ-specific diseases like cancer. Validated methods are needed for DNA modification analysis in clinical settings.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Cellular DNA constantly undergoes structural and chemical alterations from endogenous and exogenous sources.
  • An estimated 70,000 DNA lesions per cell per day can arise from metabolic processes like respiration and replication.
  • These DNA modifications are linked to various diseases, including cancer.

Purpose of the Study:

  • To investigate the basis for organ/tissue-specific cancers arising from similar levels of DNA damage.
  • To highlight the potential significance of the precise genomic location of DNA damage.
  • To emphasize the need for validated methods for DNA adduct and modification analysis.

Main Methods:

  • The study is primarily theoretical, focusing on the interpretation of existing knowledge.
  • It discusses the implications of DNA damage location within the genome.
  • It calls for the development and validation of analytical assays for DNA modifications.

Main Results:

  • The precise genomic location of DNA damage is proposed as a key factor in differential disease outcomes.
  • Similar levels of DNA damage can lead to distinct organ-specific pathologies.
  • The study identifies a gap in validated methodologies for quantifying DNA modifications.

Conclusions:

  • The genomic context of DNA lesions is critical for understanding disease specificity.
  • Validated assays for DNA adducts and modifications are essential for clinical applications.
  • Accurate measurement of DNA modifications could aid in treatment monitoring, risk assessment, and prevention strategies.

Related Concept Videos

Nucleotide Excision Repair01:46

Nucleotide Excision Repair

Exposure to mutagens can damage DNA and result in bulky lesions that distort the double-helix structure or impede proper transcription. Damaged DNA can be detected and repaired in a process called nucleotide excision repair (NER). NER employs a set of specialized proteins that first scan DNA to detect a damaged region. Next, NER proteins separate the strands and excise the damaged area. Finally, they coordinate the replacement with new, matching nucleotides.DNA distortion and damageCells are...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).